Literature DB >> 14569451

Screening colonoscopy in the asymptomatic 50- to 59-year-old population.

A Mehran1, P Jaffe, J Efron, A Vernava, A Vernavay, A Liberman.   

Abstract

BACKGROUND: In an effort to decrease the death rate from colorectal cancer, a multitude of medical societies and task forces recommend routine screening for colorectal cancer beginning at age 50. Yet, there is no consensus as to the best and most cost-effective screening method. Medicare now pays for screening colonoscopies for its average risk beneficiaries [3]. Many insurance companies, however, will not cover this test in younger patients. We therefore reviewed our institution's colonoscopy experience with asymptomatic 50- to 59-year-olds, with negative fecal occult blood tests and negative family histories.
METHODS: Between January 1999 and January 2002, 4779 colonoscopies were performed at our institution. The charts for 619 persons 50-59 years of age were retrospectively reviewed, with 91 patients meeting the strict requirements of this study. We defined polyps with high-grade neoplasias as those with villous or tubulovillous components, and cancerous lesions included those with carcinoma in situ. The distal colon was defined as the rectum and sigmoid colon.
RESULTS: There was a 58% incidence of neoplastic polyps in this younger asymptomatic population. More than 4% of our subjects had high-grade neoplasias or cancerous lesions. In the absence of any distal findings, flexible sigmoidoscopy would have missed up to 38% of these polyps.
CONCLUSIONS: The findings generally support the recommendations by the American College of Gastroenterology for average-risk patients to preferentially undergo a screening colonoscopy at age 50 in lieu of other methods.

Entities:  

Mesh:

Year:  2003        PMID: 14569451     DOI: 10.1007/s00464-003-8807-4

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  17 in total

1.  Clinical practice. Screening for colorectal cancer.

Authors:  David F Ransohoff; Robert S Sandler
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

2.  Feasibility of colonoscopy screening: discussion of issues and recommendations regarding implementation.

Authors:  D K Rex; D A Lieberman
Journal:  Gastrointest Endosc       Date:  2001-11       Impact factor: 9.427

3.  A quarter century of colorectal cancer screening: progress and prospects.

Authors:  S J Winawer
Journal:  J Clin Oncol       Date:  2001-09-15       Impact factor: 44.544

4.  Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380.

Authors:  D A Lieberman; D G Weiss; J H Bond; D J Ahnen; H Garewal; G Chejfec
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

5.  One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.

Authors:  D A Lieberman; D G Weiss
Journal:  N Engl J Med       Date:  2001-08-23       Impact factor: 91.245

6.  Patient preferences for colon cancer screening.

Authors:  M Pignone; D Bucholtz; R Harris
Journal:  J Gen Intern Med       Date:  1999-07       Impact factor: 5.128

Review 7.  Screening for colorectal cancer.

Authors:  David A Lieberman
Journal:  Clin Cornerstone       Date:  2002

8.  The National Polyp Study. Design, methods, and characteristics of patients with newly diagnosed polyps. The National Polyp Study Workgroup.

Authors:  S J Winawer; A G Zauber; M J O'Brien; L S Gottlieb; S S Sternberg; E T Stewart; J H Bond; M Schapiro; J F Panish; J D Waye
Journal:  Cancer       Date:  1992-09-01       Impact factor: 6.860

9.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.

Authors:  S J Winawer; A G Zauber; M N Ho; M J O'Brien; L S Gottlieb; S S Sternberg; J D Waye; M Schapiro; J H Bond; J F Panish
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

10.  Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history.

Authors:  D K Rex; G A Lehman; T M Ulbright; J J Smith; D C Pound; R H Hawes; D J Helper; M J Wiersema; C D Langefeld; W Li
Journal:  Am J Gastroenterol       Date:  1993-06       Impact factor: 10.864

View more
  5 in total

1.  Gender disparities in colorectal cancer screening: true or false?

Authors:  Rachel A Callcut; Stephanie Kaufman; Robert Stone-Newsom; Patrick Remington; David Mahvi
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

2.  Colonoscopy outcome in North of Iran (Guilan): 2006-2009.

Authors:  Farahnaz Joukar; Sohre Kaiidi Majd; Arezoo Fani; Nima Nazari; Fariborz Mansour-Ghanaei
Journal:  Int J Clin Exp Med       Date:  2012-08-22

3.  Geographic distribution of colonoscopy providers in the United States: An analysis of medicare claims data.

Authors:  Heather Carmichael; Jason M Samuels; Catherine G Velopulos; Edward L Jones
Journal:  Surg Endosc       Date:  2022-06-21       Impact factor: 3.453

4.  Prevalence of and risk factors for gastrointestinal diseases in korean americans and native koreans undergoing screening endoscopy.

Authors:  Hee Sun Kim; Su Jung Baik; Kyung Hee Kim; Cho Rong Oh; Jung Hyun Lee; Wan Jae Jo; Hye Kyoung Kim; Eun Young Kim; Min Jung Kim
Journal:  Gut Liver       Date:  2013-06-11       Impact factor: 4.519

5.  Polyp detection rate and pathological features in patients undergoing a comprehensive colonoscopy screening.

Authors:  Hamid Asadzadeh Aghdaei; Ehsan Nazemalhosseini Mojarad; Sara Ashtari; Mohmad Amin Pourhoseingholi; Vahid Chaleshi; Fakhrosadat Anaraki; Mehrdad Haghazali; Mohammad Reza Zali
Journal:  World J Gastrointest Pathophysiol       Date:  2017-02-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.